Research Interests
Development of targeted therapies for KRAS mutant NSCLC; Reactivation of OIS and apoptosis; Mechanisms of acquired resistance to targeted agents
Program
Molecular Pharmacology
Other Links
- At Parturient
Porta Vestibulum
Integer Sociosqu
Vitae Aptent
Aptent Praesent
Rhoncus Urna